Peripheral orphanin FQ/nociceptin analgesia in the mouse.
Y A Kolesnikov, G W Pasternak
Index: Life Sci. 64(22) , 2021-8, (1999)
Full Text: HTML
Abstract
Orphanin FQ/Nociceptin (OFQ/N) administered peripherally was an effective analgesic in the tailflick test in mice (ED50 16.3 microg). It had a peak effect at 5 min and lasted up to 30 min. The kappa3 analgesic naloxone benzoylhydrazone was also active peripherally (ED50 3.8 microg). The analgesic actions of both agents were blocked by naloxone. Neither OFQ/N(1-11) nor OFQ/N(1-7) had appreciable peripheral activity. Antisense mapping both compounds against the murine orphan opioid receptor (KOR-3) confirmed the importance of this clone in their actions. Antisense probes targeting the second and third coding exons significantly lowered the analgesic effects of both compounds. However, the antisense targeting the first coding exon blocked only the actions of OFQ/N and not kappa3 analgesia.
Related Compounds
Related Articles:
The role of nociceptin in cognition.
1999-11-27
[Brain Res. 848(1-2) , 167-73, (1999)]
Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
2006-02-01
[Br. J. Pharmacol. 147(4) , 360-70, (2006)]
Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.
2000-04-28
[Eur. J. Pharmacol. 395(2) , 149-56, (2000)]
2005-02-01
[Neuropharmacology 48(2) , 228-35, (2005)]
2004-11-01
[Br. J. Pharmacol. 143(5) , 638-48, (2004)]